InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.750 0.01 (1.32%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$204 Orthocell Receives First US CelGro Product Approval 14 Jan 2021 9:29AM $0.460 $0.750 risen by 63.04%
$204 Trading Halt 12 Jan 2021 1:31PM $0.460 $0.750 risen by 63.04%
$204 Pause in Trading 12 Jan 2021 1:12PM $0.460 $0.750 risen by 63.04%
$204 Appendix 2A and Notice Under Section 708A 7 Jan 2021 8:20AM $0.475 $0.750 risen by 57.89%
$204 CelGro Receives Australian Market Approval 23 Dec 2020 9:43AM $0.410 $0.750 risen by 82.93%
$204 CelGro Completes Pivotal Step in TGA Approval Process 17 Dec 2020 9:37AM $0.420 $0.750 risen by 78.57%
$204 Change of Director's Interest Notice * 4 23 Nov 2020 6:41PM $0.415 $0.750 risen by 80.72%
$204 Positive Results in CelGro Nerve Repair Study 20 Nov 2020 9:52AM $0.375 $0.750 risen by 100%
$204 Trading Halt 18 Nov 2020 9:36AM $0.375 $0.750 risen by 100%
$204 Appendix 4C - Quarterly 29 Oct 2020 5:58PM $0.340 $0.750 risen by 120.59%
$204 Appendix 3G 27 Oct 2020 9:57AM $0.370 $0.750 risen by 102.70%
$204 Change of Director's Interest Notice *5 20 Oct 2020 10:27AM $0.375 $0.750 risen by 100%
$204 Appendix 3G 15 Oct 2020 10:42AM $0.395 $0.750 risen by 89.87%
$204 Results of Meeting 14 Oct 2020 5:09PM $0.405 $0.750 risen by 85.19%
$204 Exercise Price of Options 14 Oct 2020 9:39AM $0.410 $0.750 risen by 82.93%
$204 Appendix 3G 8 Oct 2020 7:34PM $0.410 $0.750 risen by 82.93%
$204 Meet the CEO Investor Presentation 22 Sep 2020 9:34AM $0.400 $0.750 risen by 87.50%
$204 Revised Investor Presentation 18 Sep 2020 11:29AM $0.410 $0.750 risen by 82.93%
$204 AGM and Director Nomination Dates 18 Sep 2020 11:24AM $0.410 $0.750 risen by 82.93%
$204 CelGro Bone Regeneration in Dental & Orthopedic Applications 17 Sep 2020 9:38AM $0.420 $0.750 risen by 78.57%
$204 Investor presentation 15 Sep 2020 9:41AM $0.415 $0.750 risen by 80.72%
$204 CelGro Reaches 300 Cases Under Special Access Scheme 14 Sep 2020 10:16AM $0.400 $0.750 risen by 87.50%
$204 Letter to Shareholders - Annual General Meeting 11 Sep 2020 6:41PM $0.410 $0.750 risen by 82.93%
$204 Notice of Annual General Meeting/Proxy Form 11 Sep 2020 6:37PM $0.410 $0.750 risen by 82.93%
$204 Appendix 4E and Annual Report to Shareholders 31 Aug 2020 5:29PM $0.445 $0.750 risen by 68.54%

426 - 450 of 771 results

Page 18 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.